Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Begley

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Postgraduate Medical Journal|December 1, 1987
Colony-stimulating factors in the pathogenesis and treatment of diseaseD J Williamson, C G Begley
International Journal of Hematology|January 17, 2002
Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agentsR L Basser, C G Begley
The International Journal of Biochemistry & Cell Biology|August 8, 1998
The thrombopoietic factor, Mpl-ligandJ E Rasko, C G Begley
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1995
Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemiaN J Elwood, C G Begley
Blood|February 25, 1999
Resolving conflicting signals: cross inhibition of cytokine signaling pathwaysC G Begley, N A Nicola
Seminars in Hematology|June 1, 2000
Biologic and structural differences of thrombopoietic growth factorsC G Begley, R L Basser
The International Journal of Biochemistry & Cell Biology|December 3, 1999
The beta common chain (beta c) of the granulocyte macrophage-colony stimulating factor, interleukin-3 and interleukin-5 receptorsC L Scott, C G Begley
International Journal of Cell Cloning|September 1, 1992
SCL and related hemopoietic helix-loop-helix transcription factorsA R Green, C G Begley
Molecular Medicine Today|August 27, 1999
The oncostatin M signalling pathway: reversing the neoplastic phenotype?S L Grant, C G Begley
Journal of the American Optometric Association|March 1, 1996
The effectiveness of soft contact lens disinfection systems against Acanthamoeba on the lens surfaceK K Liedel, C G Begley
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Postgraduate Medical Journal|December 1, 1987
Colony-stimulating factors in the pathogenesis and treatment of diseaseD J Williamson, C G Begley
International Journal of Hematology|January 17, 2002
Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agentsR L Basser, C G Begley
The International Journal of Biochemistry & Cell Biology|August 8, 1998
The thrombopoietic factor, Mpl-ligandJ E Rasko, C G Begley
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 1, 1995
Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemiaN J Elwood, C G Begley
Blood|February 25, 1999
Resolving conflicting signals: cross inhibition of cytokine signaling pathwaysC G Begley, N A Nicola
Seminars in Hematology|June 1, 2000
Biologic and structural differences of thrombopoietic growth factorsC G Begley, R L Basser
The International Journal of Biochemistry & Cell Biology|December 3, 1999
The beta common chain (beta c) of the granulocyte macrophage-colony stimulating factor, interleukin-3 and interleukin-5 receptorsC L Scott, C G Begley
International Journal of Cell Cloning|September 1, 1992
SCL and related hemopoietic helix-loop-helix transcription factorsA R Green, C G Begley
Molecular Medicine Today|August 27, 1999
The oncostatin M signalling pathway: reversing the neoplastic phenotype?S L Grant, C G Begley
Journal of the American Optometric Association|March 1, 1996
The effectiveness of soft contact lens disinfection systems against Acanthamoeba on the lens surfaceK K Liedel, C G Begley
Pageof 19